We studied the effect of Leu-Ile-Lys tripeptide on the course of experimental oxalate nephrolithiasis modeled in rats by administration of 1% ethylene glycol solution instead of drinking water for 6 weeks. The Leu-Ile-Lys tripeptide obtained by chemical synthesis (purity ≥98%) was administered through a gastric tube (11.5 mg/kg in 1 ml saline). Administration of Leu-Ile-Lys tripeptide against the background of experimental oxalate nephrolithiasis significantly alleviated the course of experimental pathology, which was confirmed by typical biochemical and morphological changes: decrease in urinary activity of γ-glutamyltransferase (by 2.1 times in comparison with the initial level) and intensity of oxidative stress (the content of TBA-reactive products decreased by 1.3 times in comparison with that in untreated animals) and increase in glutathione peroxidase activity by 1.8 times; no histological signs of nephrolithiasis were found in animals treated with the tripeptide.
Similar content being viewed by others
References
Karabaeva AZ, Parastaeva MM, Beresneva ON, Smirnov AV, Essaian AM, Kayukov IG. The influence of spironolactone on the course of experimental chronic renal failure and myocardium hypertrophy in Wistar rats. Nefrologiya. 2008;12(1):69-74. Russian.
Bryukhanov VM, Zverev YaF, Lampatov VV, Zharikov AYu, Talalaeva OS. Methods of Preclinical (Experimental) Study of the Effect of Drugs on the Kidney Function. Novosibirsk, 2013. Russian.
Garicov AU, Bruhanov VM, Zverev YaF, Lampatov VV. Current methods of modeling of oxalate nephrolythiasis. Nefrologiya. 2008;12(4):28-35. Russian.
Zharikov AY, Kiselev VI, Saldan IP, Zharikova GV, Lepilov AV, Bobrov IP. Morphological Evaluation of the Influence of the Peptide Complex from Tissue of Porcine Kidneys on the Experimental Urolithiasis. Bull. Exp. Biol. Med. 2017;164(2):207-210. doi: https://doi.org/10.1007/s10517-017-3959-8
Zharikova GV, Zharikov AY, Kiselev VI, Mazko ON, Makarova OG, Kiryakova VO. The influence of the peptide complex of pig kidneys on the free radical oxidation by experimental urolithiasis. Sib. Nauch. Med. Zh. 2017;37(2):17-21. Russian.
Khafaziyanova RKh, Burykin IM, Aleeva GN. Mathematical Statistics in Experimental and Clinical Pharmacology. Kazan, 2006. Russian.
Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv. Urol. 2018;2018. ID 3068365. doi: https://doi.org/10.1155/2018/3068365
Khan SR. Stress oxidative: nephrolithiasis and chronic kidney diseases. Minerva Med. 2013;104(1):23-30.
Khan SR. Histological aspects of the “fixed-particle” model of stone formation: animal studies. Urolithiasis. 2012;45(1):75-87.
Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K, Kohri K. Pathophysiology-based treatment of urolithiasis. Int. J. Urol. 2017;24(1):32-38.
Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig. Clin. Urol. 2017;58(5):299-306.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 6, pp. 704-708, June, 2019
Rights and permissions
About this article
Cite this article
Zharikov, A.Y., Yakushev, N.N., Zharikova, G.V. et al. Effect of Tripeptide Leu-Ile-Lys on the Course of Experimental Nephrolithiasis. Bull Exp Biol Med 167, 747–750 (2019). https://doi.org/10.1007/s10517-019-04614-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-019-04614-w